Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania

BACKGROUND: The World Health Organization recommends artemisinin-based combination (ACT) for the treatment of uncomplicated malaria. Post-licensure safety data on newly registered ACT is critical for evaluating their risk/benefit profile in malaria endemic countries. The clinical safety of the newly...

Descripción completa

Detalles Bibliográficos
Autores principales: Baiden, Rita, Oduro, Abraham, Halidou, Tinto, Gyapong, Margaret, Sie, Ali, Macete, Eusebio, Abdulla, Salim, Owusu-Agyei, Seth, Mulokozi, Abdunoor, Adjei, Alex, Sevene, Esperanca, Compaoré, Guillaume, Valea, Innocent, Osei, Isaac, Yawson, Abena, Adjuik, Martin, Akparibo, Raymond, Ogutu, Bernhards, Upunda, Gabriel Leonard, Smith, Peter, Binka, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405867/
https://www.ncbi.nlm.nih.gov/pubmed/25885858
http://dx.doi.org/10.1186/s12936-015-0664-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405867/
https://www.ncbi.nlm.nih.gov/pubmed/25885858
http://dx.doi.org/10.1186/s12936-015-0664-9

Ejemplares similares